ACCU-CHEK Connect Personal Diabetes Management Study (PDM CONNECT)

  • Metabolic Disorder
  • Type 1 Diabetes Mellitus
Please note that the recruitment status of the study at your site may differ from the overall study status because some study sites may recruit earlier than others.
Study Status:

Completed

This study runs in
Cities
  • Atlanta
  • Bristol
  • Huntington Beach
  • Lincoln
  • Macon
  • Montgomery
  • Ocean Springs
  • Plano
  • Pottstown
  • Raleigh
  • Wilmington
Trial Identifier:

NCT02600845 RD002206

      Show study locations

      The source of the below information is public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc.. It has been summarised and edited into simpler language. For more information about this clinical study see the For Expert tab on the specific ForPatients page or follow these links to https://clinicaltrials.gov and/or https://euclinicaltrials.eu and/or https://www.isrctn.com.

      The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc., and has not been edited.

      Results Disclaimer

      Study Summary

      This post-market, interventional, prospective, single arm, the United States (US) based multi-center study will assess the change in treatment satisfaction of participants who utilize the ACCU-CHEK Connect Diabetes Management System over a period of 6 months.

      Hoffmann-La Roche Sponsor
      N/A Phase
      NCT02600845, RD002206 Trial Identifier
      ACCU-CHEK Treatments
      Diabetes Mellitus, Type 1 Condition
      Official Title

      ACCU-CHEK Connect Personal Diabetes Management Study (PDM)

      For the latest version of this information please go to www.forpatients.roche.com

       

      Related Studies

      Use our search to find other trials on Genentech Clinical Trials in related disease areas.

      Type 1 Diabetes Mellitus

      About Clinical Research

      What is a clinical trial? Why should I consider taking part in a clinical trial? And why does Genentech conduct clinical trials?

      Find out now